Raleigh, NC – March 9, 2015 – Valencell, a leader in performance biometric data sensor technology, today announced that President and co-founder Dr. Steven LeBoeuf and Director of Exercise Science and Clinical Trials, Dr. Chris Eschbach, will participate in discussions and teach classes around biometric wearable accuracy and critical factors for long-term product adoption at the Wearables TechCon event being held in Santa Clara, CA from March 9 – 11.

Dr. Steven LeBoeuf will lead a class session “Preventing Death by Discharge in Your Wearable Devices” on Monday, March 9 at 8:30 am. Attendees will learn how to apply biometric data to storyboard applications that deliver valuable insight to consumers before each recharge in their wearable products, resulting in continued use.

Later that day, LeBoeuf will participate in a panel session “Panelist for Ethics: Wearables, Data Collection and Privacy” at 2:45 pm. The panel will take a look at the ethics and best practices in creating and developing applications and wearable devices that collect and use sensitive content.

Dr. Chris Eschbach will lead a class session on Tuesday, March 10 at 2:15 pm on “Proven Techniques for Clinically Validating Biometric Wearable Sensors for Real-Life Use Cases.” During this class, attendees will learn how to validate biometric wearable sensors against established clinical benchmarks to prevent garbage-in/garbage-out with wearable products.

Additionally, Eschbach will participate in a panel session on Tuesday at 4:00 pm, “Quantified Self: Fitness Devices and Apps,” that will take a look at the variety of features and functionality that are currently available and which will resonate most with users for long-term adoption.

The Wearables TechCon event attracts thousands of OEM builders, designers and developers of wearable computing technology. The event will take place from March 9 – 11 at the Hyatt Regency in Santa Clara, CA. For more information, visit http://www.wearablestechcon.com/

About Valencell

Founded in 2006 and headquartered in Raleigh, North Carolina, Valencell develops performance biometric sensor technology and licenses this patent-protected technology to consumer electronics manufacturers, mobile device and accessory makers, sports and fitness brands, first responder/military markets, consumer healthcare brands, and gaming companies for integration into their products. Valencell’s PerformTek sensor technology powers the most accurate wearable biometric sensors that continuously measure heart rate and activity. Valencell has invested years into research and development of its PerformTek sensor technology, protected by dozens of granted patents and independently validated by the Duke Center for Living, North Carolina State University, the Human Performance Laboratory and a fellow of the American College of Sports Medicine.